Tom Y. Lee - Sep 30, 2022 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Tom Lee
Stock symbol
PURE
Transactions as of
Sep 30, 2022
Transactions value $
$0
Form type
4
Date filed
10/4/2022, 04:24 PM
Previous filing
Jul 19, 2022
Next filing
Dec 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PURE Stock Option (Right to Buy) Award $0 +125K $0.00 125K Sep 30, 2022 Common Stock 125K $0.20 Direct F1
transaction PURE Stock Option (Right to Buy) Award $0 +200K $0.00 200K Sep 30, 2022 Common Stock 200K $0.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024.
F2 The option shares shall vest and become exercisable in four equal installments December 30, 2022, March 30, 2023, June 30, 2023, and September 30, 2023.